New drug duo tested in fight against advanced cervical cancer
Disease control
Ongoing
This study is testing whether a combination of two immunotherapy drugs, dostarlimab and cobolimab, can help control advanced cervical cancer that has spread or come back. It will involve about 66 adults whose cancer has progressed after standard platinum-based chemotherapy. The m…
Phase: PHASE2 • Sponsor: Meghan Shea • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC